Article

Effective Use of ALK Inhibitors in EML4::ALK Positive Lymphatic Malformations

2024-08-27

Abstract excerpt

Genetically-targeted medications are emerging as important therapies for lymphatic malformations (LMs) unresponsive to sirolimus. We describe two patients with EML4::ALK positive LMs, one with Gorham Stout Disease and one with a large genitourinary (GU) LM, who were successfully treated with ALK inhibitors. This report adds ALK inhibitors to the growing toolbox of molecularly-targeted therapies for LMs.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1a1e8481-deab-576e-a4ef-65f7c610d05d
DOI: 10.22541/au.172479007.75025040/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effective Use of ALK Inhibitors in EML4::ALK Positive Lymphatic MalformationsDOI 10.22541/au.172479007.75025040/v1Read

EML4::ALK Fusions In Complex Lymphatic MalformationsSemantic proximity Read

Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for TherapySemantic proximity Read

NRAS mutation in a central conducting lymphatic anomaly and PPFIBP1::ROS1 fusion in a Gorham-stout disease patient.Semantic proximity Read

Genomic Landscape of Lymphatic Malformations: A Case Series and Response to the PI3Kα Inhibitor Alpelisib in an N-of-One Clinical TrialSemantic proximity Read

Life-threatening Lymphatic Malformation With Somatic Activating NRAS Mutation Successfully Treated With Trametinib: A Case StudySemantic proximity Read

Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial.Semantic proximity Read

Exploring Lymphangioma: A Synthesis of Literature and Clinical PerspectivesSemantic proximity Read

Targeted Therapy for Complex Lymphatic Anomalies in Patients with Noonan Syndrome and Related DisordersSemantic proximity Read

Genetic causes of lymphatic disorders: recent updates on the clinical and molecular aspects of lymphatic disease.Semantic proximity Read

Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies.Semantic proximity Read

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF VariantSemantic proximity Read

How we approach the diagnosis and management of complex lymphatic anomaliesSemantic proximity Read